“Today, Novo Nordisk charges Americans with Type 2 diabetes $969 a month for Ozempic, while this same exact drug can be purchased for just $59 in Germany, $71 in France, $122 in Denmark, and $155 in Canada. There is only one reason they can justify charging Americans such outrageous prices for the drugs they need: Excessive corporate greed.”